Table 4 Multivariable logistic regression of factors associated with mixed C/B-BSIs
Risk factors | B | S.E | Wald | P value | aOR (95% CI) |
|---|---|---|---|---|---|
Prior hospital stay (days) | 0.00 | 0.01 | 0.02 | 0.88 | 1.00 (0.99–1.01) |
Prior antibiotic exposure | 0.88 | 0.53 | 2.76 | 0.10 | 2.42 (0.85–6.85) |
Prior β-lactams exposure | 0.68 | 0.34 | 3.93 | 0.05 | 1.97 (1.01–3.87) |
Initial antifungal agent was Echinocandin | 0.56 | 0.33 | 3.01 | 0.08 | 1.76 (0.93–3.33) |
Prior ICU stay (days) | 0.01 | 0.01 | 1.15 | 0.28 | 1.01 (0.99–1.02) |
Burn injury | 1.85 | 0.64 | 8.38 |  < 0.01 | 6.35 (1.82–22.21) |
ECMO | 1.15 | 1.20 | 0.92 | 0.34 | 3.16 (0.30–33.31) |
CRRT | 1.10 | 0.37 | 8.88 |  < 0.01 | 3.00 (1.46–6.17) |
Invasive mechanical ventilation | 0.24 | 0.43 | 0.31 | 0.58 | 1.27 (0.54–2.98) |
Total parenteral nutrition | 0.64 | 0.36 | 3.10 | 0.08 | 1.89 (0.93–3.85) |
Blood transfusion | 0.39 | 0.33 | 1.45 | 0.23 | 1.48 (0.78–2.81) |
ICU admission | -0.52 | 0.43 | 1.41 | 0.24 | 0.60 (0.25–1.40) |
Lactic acid | 0.06 | 0.06 | 0.87 | 0.35 | 1.06 (0.94–1.19) |
Procalcitonin | 0.02 | 0.01 | 2.34 | 0.13 | 1.02 (0.99–1.04) |
SOFA score | 0.03 | 0.05 | 0.48 | 0.49 | 1.03 (0.94–1.14) |
Peripheral arterial catheters | -0.22 | 0.37 | 0.33 | 0.56 | 0.81 (0.39–1.68) |
Thoracic drainage tube | 0.56 | 0.40 | 1.95 | 0.16 | 1.75 (0.80–3.85) |
Constant | -3.86 | 0.64 | 36.68 |  < 0.01 | 0.02 (–) |